Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts
Most cases of hepatocellular carcinoma (HCC) arise with the fibrotic microenvironment where hepatic stellate cells (HSCs) and carcinoma-associated fibroblasts (CAFs) are critical components in HCC progression. Therefore, CAF normalization could be a feasible therapy for HCC. Galectin-1 (Gal-1), a be...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Published: |
Springer Nature
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/42878/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.42878 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.428782023-10-06T07:23:25Z http://eprints.um.edu.my/42878/ Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts Tsai, Yao-Tsung Li, Chih-Yi Huang, Yen-Hua Chang, Te-Sheng Lin, Chung-Yen Chuang, Chia-Hsien Wang, Chih-Yang Anuraga, Gangga Chang, Tzu-Hao Shih, Tsung-Chieh Lin, Zu-Yau Chen, Yuh-Ling Chung, Ivy Lee, Kuen-Haur Chang, Che-Chang Sung, Shian-Ying Yang, Kai-Huei Tsui, Wan-Lin Yap, Chee-Voon Wu, Ming-Heng R Medicine RM Therapeutics. Pharmacology Most cases of hepatocellular carcinoma (HCC) arise with the fibrotic microenvironment where hepatic stellate cells (HSCs) and carcinoma-associated fibroblasts (CAFs) are critical components in HCC progression. Therefore, CAF normalization could be a feasible therapy for HCC. Galectin-1 (Gal-1), a beta-galactoside-binding lectin, is critical for HSC activation and liver fibrosis. However, few studies has evaluated the pathological role of Gal-1 in HCC stroma and its role in hepatic CAF is unclear. Here we showed that Gal-1 mainly expressed in HCC stroma, but not cancer cells. High expression of Gal-1 is correlated with CAF markers and poor prognoses of HCC patients. In co-culture systems, targeting Gal-1 in CAFs or HSCs, using small hairpin (sh)RNAs or an therapeutic inhibitor (LLS30), downregulated plasminogen activator inhibitor-2 (PAI-2) production which suppressed cancer stem-like cell properties and invasion ability of HCC in a paracrine manner. The Gal-1-targeting effect was mediated by increased a disintegrin and metalloprotease 17 (ADAM17)-dependent TNF-receptor 1 (TNFR1) shedding/cleavage which inhibited the TNF-alpha -> JNK -> c-Jun/ATF2 signaling axis of pro-inflammatory gene transcription. Silencing Gal-1 in CAFs inhibited CAF-augmented HCC progression and reprogrammed the CAF-mediated inflammatory responses in a co-injection xenograft model. Taken together, the findings uncover a crucial role of Gal-1 in CAFs that orchestrates an inflammatory CSC niche supporting HCC progression and demonstrate that targeting Gal-1 could be a potential therapy for fibrosis-related HCC. Springer Nature 2022-05 Article PeerReviewed Tsai, Yao-Tsung and Li, Chih-Yi and Huang, Yen-Hua and Chang, Te-Sheng and Lin, Chung-Yen and Chuang, Chia-Hsien and Wang, Chih-Yang and Anuraga, Gangga and Chang, Tzu-Hao and Shih, Tsung-Chieh and Lin, Zu-Yau and Chen, Yuh-Ling and Chung, Ivy and Lee, Kuen-Haur and Chang, Che-Chang and Sung, Shian-Ying and Yang, Kai-Huei and Tsui, Wan-Lin and Yap, Chee-Voon and Wu, Ming-Heng (2022) Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts. Oncogene, 41 (21). pp. 3011-3023. ISSN 0950-9232, DOI https://doi.org/10.1038/s41388-022-02309-7 <https://doi.org/10.1038/s41388-022-02309-7>. 10.1038/s41388-022-02309-7 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
R Medicine RM Therapeutics. Pharmacology |
spellingShingle |
R Medicine RM Therapeutics. Pharmacology Tsai, Yao-Tsung Li, Chih-Yi Huang, Yen-Hua Chang, Te-Sheng Lin, Chung-Yen Chuang, Chia-Hsien Wang, Chih-Yang Anuraga, Gangga Chang, Tzu-Hao Shih, Tsung-Chieh Lin, Zu-Yau Chen, Yuh-Ling Chung, Ivy Lee, Kuen-Haur Chang, Che-Chang Sung, Shian-Ying Yang, Kai-Huei Tsui, Wan-Lin Yap, Chee-Voon Wu, Ming-Heng Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts |
description |
Most cases of hepatocellular carcinoma (HCC) arise with the fibrotic microenvironment where hepatic stellate cells (HSCs) and carcinoma-associated fibroblasts (CAFs) are critical components in HCC progression. Therefore, CAF normalization could be a feasible therapy for HCC. Galectin-1 (Gal-1), a beta-galactoside-binding lectin, is critical for HSC activation and liver fibrosis. However, few studies has evaluated the pathological role of Gal-1 in HCC stroma and its role in hepatic CAF is unclear. Here we showed that Gal-1 mainly expressed in HCC stroma, but not cancer cells. High expression of Gal-1 is correlated with CAF markers and poor prognoses of HCC patients. In co-culture systems, targeting Gal-1 in CAFs or HSCs, using small hairpin (sh)RNAs or an therapeutic inhibitor (LLS30), downregulated plasminogen activator inhibitor-2 (PAI-2) production which suppressed cancer stem-like cell properties and invasion ability of HCC in a paracrine manner. The Gal-1-targeting effect was mediated by increased a disintegrin and metalloprotease 17 (ADAM17)-dependent TNF-receptor 1 (TNFR1) shedding/cleavage which inhibited the TNF-alpha -> JNK -> c-Jun/ATF2 signaling axis of pro-inflammatory gene transcription. Silencing Gal-1 in CAFs inhibited CAF-augmented HCC progression and reprogrammed the CAF-mediated inflammatory responses in a co-injection xenograft model. Taken together, the findings uncover a crucial role of Gal-1 in CAFs that orchestrates an inflammatory CSC niche supporting HCC progression and demonstrate that targeting Gal-1 could be a potential therapy for fibrosis-related HCC. |
format |
Article |
author |
Tsai, Yao-Tsung Li, Chih-Yi Huang, Yen-Hua Chang, Te-Sheng Lin, Chung-Yen Chuang, Chia-Hsien Wang, Chih-Yang Anuraga, Gangga Chang, Tzu-Hao Shih, Tsung-Chieh Lin, Zu-Yau Chen, Yuh-Ling Chung, Ivy Lee, Kuen-Haur Chang, Che-Chang Sung, Shian-Ying Yang, Kai-Huei Tsui, Wan-Lin Yap, Chee-Voon Wu, Ming-Heng |
author_facet |
Tsai, Yao-Tsung Li, Chih-Yi Huang, Yen-Hua Chang, Te-Sheng Lin, Chung-Yen Chuang, Chia-Hsien Wang, Chih-Yang Anuraga, Gangga Chang, Tzu-Hao Shih, Tsung-Chieh Lin, Zu-Yau Chen, Yuh-Ling Chung, Ivy Lee, Kuen-Haur Chang, Che-Chang Sung, Shian-Ying Yang, Kai-Huei Tsui, Wan-Lin Yap, Chee-Voon Wu, Ming-Heng |
author_sort |
Tsai, Yao-Tsung |
title |
Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts |
title_short |
Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts |
title_full |
Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts |
title_fullStr |
Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts |
title_full_unstemmed |
Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts |
title_sort |
galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing tnfr1 protein stability and signaling in carcinoma-associated fibroblasts |
publisher |
Springer Nature |
publishDate |
2022 |
url |
http://eprints.um.edu.my/42878/ |
_version_ |
1781704655809544192 |
score |
13.211869 |